Simoa® NF-light™: Ultrasensitive Blood-Based Biomarker Detection for Identification of Neuropathology

App Note

Survivors of cardiac arrest and prolonged open-heart surgery have increased risks of developing adverse neurological outcomes in the long term^1,2. Identifying high-risk patients at an early stage allows clinicians to propose better therapeutic strategies, resulting in significant improvements in patient management and quality of life. Download our app note to learn how detection of NfL with Simoa® can support the identification of neuropathology and could help improve therapeutic management.

1. Perkins GD, Callaway CW, Haywood K, et al. Brain injury after cardiac arrest. The Lancet. 2021;398(10307):1269-1278. doi:10.1016/s0140-6736(21)00953-3

2. Raffa GM, Agnello F, Occhipinti G, et al. Neurological complications after cardiac surgery: a retrospective case-control study of risk factors and outcome. Journal of Cardiothoracic Surgery. 2019;14(1)doi:10.1186/s13019-019-0844-8

If you see this, do not fill:

Fill in the form below.

First Name *
Last Name *
Email *
Company *
What type of organization is your company? *
Country *
State *
Postal Code *
Phone
I consent
By submitting this form, you agree to Quanterix’s Terms of Use and Privacy Policy. In addition, you agree to receive information regarding Quanterix products and services. You will be able to unsubscribe at any time.